Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1995-3-8
|
pubmed:abstractText |
The controversy over the route of administration of antibiotic prophylaxis in patients undergoing elective colorectal operations persists for oral, parenteral, and a combination of the two routes. The oral antibiotics commonly administered for colorectal prophylaxis, neomycin and eythromycin base, are not absorbed in the gastrointestinal tract (GIT). However, the 4-fluoroquinolones are absorbed in the upper GIT and are excreted in part by the colonic mucosa. Their action is then to remove, or severely depress, the gram-negative aerobic bacilli leaving the anaerobic flora unaffected. This action is the principle of selective decontamination. We have assessed the efficacy of oral ciprofloxacin in a prospective randomized clinical trial in which all patients received piperacillin 4 g i.v. as single-dose parenteral prophylaxis. A group of 327 evaluable patients were randomized to receive ciprofloxacin 500 mg b.i.d. with the preoperative cathartic (group OA, n = 159) or no oral antibiotic (group NOA, n = 168). Postoperative wound infection occurred in 18 (11.3%) patients in group OA and 39 (23.2%) patients in group NOA (chi 2 = 7.2, p = 0.007). Operation-related infection of any type occurred in 23 (14.5%) patients in group OA compared with 55 (32.7%) in group NOA (chi 2 = 14.0, p = 0.0002). The median postoperative hospital stay was 11 days (interquartile range 4.5 days) for group OA and 12 days (interquartile range 8 days) for group NOA (Mann Whitney U test, p = 0.005). Ignoring the treatment group, the median postoperative hospital stay was 17 days (interquartile range 10 days) for infected patients and 11 days (interquartile range 4 days) for those not infected.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0364-2313
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
926-31; discussion 931-2
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7846921-Adult,
pubmed-meshheading:7846921-Aged,
pubmed-meshheading:7846921-Aged, 80 and over,
pubmed-meshheading:7846921-Ciprofloxacin,
pubmed-meshheading:7846921-Colon,
pubmed-meshheading:7846921-Decontamination,
pubmed-meshheading:7846921-Female,
pubmed-meshheading:7846921-Humans,
pubmed-meshheading:7846921-Length of Stay,
pubmed-meshheading:7846921-Male,
pubmed-meshheading:7846921-Middle Aged,
pubmed-meshheading:7846921-Preoperative Care,
pubmed-meshheading:7846921-Rectum,
pubmed-meshheading:7846921-Surgical Procedures, Elective,
pubmed-meshheading:7846921-Surgical Wound Infection
|
pubmed:articleTitle |
Selective decontamination of the colon before elective colorectal surgery. West of Scotland Surgical Infection Study Group.
|
pubmed:affiliation |
Vale of Leven Hospital, Alexandria, Scotland, U.K.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|